Atlas Trials

The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy

Clinical trial NCT02573636 · RECRUITING

Trial details

NCT number
NCT02573636
Sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2016-03-01
Primary completion
2026-11-01
Enrollment
208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.